Immunoprotection against influenza H5N1 virus by oral administration of enteric-coated recombinant Lactococcus lactis mini-capsules

Virology

Volumn 407, Issue 2, 2010, Pages 319-324

  Lei, Han ^a,b   Xu, Yuhong ^a   Chen, Jian ^a   Wei, Xiaohui ^a   Lam, Dominic Man Kit ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b NANCHANG UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Edible vaccines; Enteric coating; H5N1 virus; Recombinant Lactococcus lactis

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA VIRUS HEMAGGLUTININ; PROBIOTIC AGENT; EDIBLE VACCINE; ENTERIC COATED TABLET; INFLUENZA VACCINE; MICROCAPSULE; RECOMBINANT VACCINE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG CAPSULE; DRUG DOSAGE FORM; EXPRESSION VECTOR; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; INFECTION PREVENTION; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; LACTOCOCCUS LACTIS; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SURVIVAL RATE; VIRUS VIRULENCE; ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD; ENTERIC COATED TABLET; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MICROCAPSULE; ORAL DRUG ADMINISTRATION; ORTHOMYXOVIRIDAE INFECTIONS; T LYMPHOCYTE; VIROLOGY;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; CAPSULES; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; LACTOCOCCUS LACTIS; MICE; ORTHOMYXOVIRIDAE INFECTIONS; T-LYMPHOCYTES; TABLETS, ENTERIC-COATED; VACCINES, EDIBLE; VACCINES, SYNTHETIC;

ANIMALIA; LACTOCOCCUS LACTIS;

EID: 77957673456     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.08.007     Document Type: Article

References (30)

1. Bahey-El-Din M., Casey P., Griffin B., Gahan C. Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8+ T cells against Listeria monocytogenes in the murine infection model. Vaccine 2008, 26(41):5304-5314.
2. Bright R.A., Ross T.M., Subbarao K., Robinson H.L., Katz J.M. Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine. Virology 2003, 308(2):270-278.
3. Chen M., Cheng T., Huang Y., Jan J., Ma S., Yu A., Wong C., Ho D. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc. Natl Acad. Sci. 2008, 105(36):13538-13543.
4. Cho H., Shin H., Han I., Jung W., Kim Y., Sul D., Oh Y. Induction of mucosal and systemic immune responses following oral immunization of mice with Lactococcus lactis expressing human papillomavirus type 16 L1. Vaccine 2007, 25(47):8049-8057.
5. De Ruyter P., Kuipers O., De Vos W. Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl. Environ. Microbiol. 1996, 62(10):3662-3687.
6. Duan L., Bahl J., Smith G.J.D., Wang J., Vijaykrishna D., Zhang L.J., Zhang J.X., Li K.S., Fan X.H., Cheung C.L., Huang K., Poon L.L.M., Shortridge K.F., Webster R.G., Peiris J.S.M., Chen H., Guan Y. The development and genetic diversity of H5N1 influenza virus in China, 1996-2006. Virology 2008, 380(2):243-254.
7. Eichelberger M., Golding H., Hess M., Weir J., Subbarao K., Luke C., Friede M., Wood D. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11. Vaccine 2007, 26(34):4299-4303.
8. Gao W., Soloff A., Lu X., Montecalvo A., Nguyen D., Matsuoka Y., Robbins P., Swayne D., Donis R., Katz J. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J. Virol. 2006, 80(4):1959-1964.
9. Gilbert C., Robinson K., Le Page R., Wells J. Heterologous expression of an immunogenic pneumococcal type 3 capsular polysaccharide in Lactococcus lactis. Infect. Immun. 2000, 68(6):3251-3260.
10. Grangette C., Müller-Alouf H., Geoffroy M., Goudercourt D., Turneer M., Mercenier A. Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence. Vaccine 2002, 20(27-28):3304-3309.
11. Gruzza M., Fons M., Ouriet M., Duval-Iflah Y., Ducluzeau R. Study of gene transfer in vitro and in the digestive tract of gnotobiotic mice from Lactococcus lactis strains to various strains belonging to human intestinal flora. Microb. Releases 1994, 2(4):183-189.
12. Hoelscher M., Garg S., Bangari D., Belser J., Lu X., Stephenson I., Bright R., Katz J., Mittal S., Sambhara S. Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet 2006, 367(9509):475-481.
13. Johansson B., Brett I., Focosi D., Poland G. An inactivated subvirion influenza A (H5N1) vaccine. N Engl J. Med. 2006, 354(25):2724-2725.
14. Katz J.M., Lu X., Young S.A., Galphin J.C. Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Eschrichia coli for oral administration of inactivated influenza virus vaccine. J. Infect. Dis. 1997, 175(2):352-363.
15. Kilbourne E., Smith C., Brett I., Pokorny B., Johansson B., Cox N. The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc. Natl Acad. Sci. 2002, 99(16):10748-10752.
16. Kimoto H., Nomura M., Kobayashi M., Mizumachi K., Okamoto T. Survival of lactococci during passage through mouse digestive tract. Can. J. Microbiol. 2003, 49(11):707-711.
17. Klijn N., Weerkamp A., De Vos W. Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl. Environ. Microbiol. 1995, 61(7):2771-2774.
18. Kong W., Hood C., Yang Z., Wei C., Xu L., García-Sastre A., Tumpey T., Nabel G. Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination. Proc. Natl Acad. Sci. 2006, 103(43):15987-15991.
19. Lam D.M.K., Shi J. Edible vaccines. Agro-Food-Ind. High-Tech. 1996, 11(2):7-12.
20. Lam D.M.K., Shi J., Zhang X.Y. Edible vaccines produced by transgenic vegetables and fruit. Foreign Med. Sci. 1997, 20(4):145-149.
21. Mason H., Lam D., Arntzen C. Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl Acad. Sci. 1992, 89(24):11745-11749.
22. Mercenier A., Pavan S., Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr. Pharm. Des. 2003, 9(2):175-191.
23. Nochi T., Takagi H., Yuki Y., Yang L., Masumura T., Mejima M., Nakanishi U., Matsumura A., Uozumi A., Hiroi T. Rice-based mucosal vaccine as a global strategy for cold-chain-and needle-free vaccination. Proc. Natl Acad. Sci. 2007, 104(26):10986-10991.
24. Robinson K., Chamberlain L., Schofield K., Wells J., Le Page R. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat. Biotechnol. 1997, 15(7):653-657.
25. Rohm C., Horimoto T., Kawaoka Y., Süss J., Webster R. Do hemagglutinin genes of highly pathogenic avian influenza viruses constitute unique phylogenetic lineages?. Virology 1995, 209(2):664-670.
26. Rowe T., Abernathy R., Hu-Primmer J., Thompson W., Lu X., Lim W., Fukuda K., Cox N., Katz J. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 1999, 37(4):937-943.
27. Steidler L., Neirynck S., Huyghebaert N., Snoeck V., Vermeire A., Goddeeris B., Cox E., Remon J., Remaut E. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. Biotechnol. 2003, 21(27):785-789.
28. Subbarao K., Klimov A., Katz J., Regnery H., Lim W., Hall H., Perdue M., Swayne D., Bender C., Huang J. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998, 279(5349):393-396.
29. Wei C., Xu L., Kong W., Shi W., Canis K., Stevens J., Yang Z., Dell A., Haslam S., Wilson I. Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J. Virol. 2008, 82(13):6200-6208.
30. Xin K., Hoshino Y., Toda Y., Igimi S., Kojima Y., Jounai N., Ohba K., Kushiro A., Kiwaki M., Hamajima K. Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env. Blood 2003, 102(1):223-238.